MRRSE has added a new research report on the "Global Market Study on Transcatheter Heart Valve Replacement and Repair: High Demand For Minimally Invasive Surgeries in Aortic Stenosis Cases to Drive the Market for THVR During the Forecast Period" to its collection.

1. Transcatheter Heart Valve Replacement and Repair Market
Detailed Analysis and Forecast by 2019
Report Description
Transcatheter heart valve implantation is a procedure with
less invasive approach helps in replacing the heart valve with
prosthetic valve for treatment of severe aortic stenosis and

2. mitral regurgitation. It is the effective alternative to
cumbersome open heart surgery especially for high risk
patients. The procedure helps reduce severe degenerative
aortic stenosis and increases survival rate of patients.
Increasing percutaneous transcatheter prosthetic valve
implantation worldwide is expected to drive demand for
transcatheter heart valve devices, as risk of valvular heart
disease is higher among geriatric population, owing to
increasing prevalence of severe aortic stenosis and
asymptomatic severe mitral regurgitation.
The global transcatheter heart valve replacement & repair
market was valued at US$ 1,605.5 Mn in 2015 and is

3. expected to expand at a CAGR of 13.9% over the forecast
period (2016–2026).
Request a Sample Copy of the Report @
http://www.mrrse.com/sample/2291
Drivers and Trends
The prime driver for the transcatheter heart valve
replacement & repair market is rising demand for less
invasive procedure for high risk patients, growing prevalence
of mitral regurgitation and severe aortic stenosis disorder.
Moreover, shorter recovery time, less stay in the hospitals,
favorable outcomes with transcatheter prosthetic valve

4. implantation and technological advancements are also driving
adoption of transcatheter heart valve devices. However, high
costs of transcatheter heart valves, risk associated with
procedure and certain device related issue such as product
recalls by manufacturers, malpositioning during implantation
impede growth of the market to a certain extent.
Inquiry on this report @ http://www.mrrse.com/enquiry/2291
Market Segmentation by Product Type
On the basis of product type, the market has been segmented
into transcatheter aortic valve replacement (TAVR) and

5. transcatheter mitral valve repair (TMVR). In terms of value,
TAVR segment is expected to account for 79.9% market share
in global transcatheter heart valve replacement & repair
market by 2026 end.
Market Segmentation by Surgical Approach
On the basis of surgical approach, the market has been
segmented into transfemoral approach, transapical approach
and transaortic approach. Transfemoral segment accounted for
highest market share of 82.1% in 2015 and is expected to
retain its dominance throughout the forecast period.
Increasing focus on investigational products by various

6. vendors boost the market growth of transcatheter valves
across the globe.
Read Complete Report with TOC @
http://www.mrrse.com/transcatheter-heart-valve-replacement-
repair-market
Market Segmentation by End User
On the basis of end user, the market has been segmented
into hospitals, ambulatory surgical centres and cardiac
catheterization laboratory. Hospital segment is expected to
exhibit the highest growth over the forecast period, followed
by cardiac catheterization laboratory segment. Increasing

7. patient population seeking effective and efficient treatment
with shorter recovery time are key factors driving adoption
of new medical devices and technologies in hospitals.
Key Regions
The global transcatheter heart valve replacement & repair
market has been segmented into five major regions namely
North America, Latin America, Western Europe, Eastern
Europe, Asia Pacific excluding Japan, Japan and Middle East
& Africa (MEA). In terms of value, the North America market
is estimated to dominate the global transcatheter heart valve
replacement & repair market in 2016, and is expected to
expand at a CAGR of 14.2% over the forecast period. Asia

8. Pacific excluding Japan, MEA, and Latin America are
expected to be the fastest growing markets over the forecast
period. Asia Pacific excluding Japan market is expected to
witness highest CAGR of 13.9 % over the forecast period. In
North America, segment is expected to grow at faster rate to
reach the value US$ 3,552.4 Mn by 2026 end. Market in
Europe is expected to exhibit healthy CAGR owing to growing
acceptance of THV products in the region.
Key Players
Some of the key players in the global transcatheter heart
valve replacement & repair market are Edwards Lifesciences
Corporation, Medtronic, Inc., Boston Scientific Corporation,

9. Abbott Laboratories, St. Jude Medical, Inc., St. Jude Medical,
Inc., JenaValve Technology, SYMETIS, Braile Biomedica.
About MRRSE
MRRSE stands for Market Research Reports Search Engine,
the largest online catalog of latest market research reports
based on industries, companies, and countries. MRRSE
sources thousands of industry reports, market statistics, and
company profiles from trusted entities and makes them
available at a click. Besides well-known private publishers,
the reports featured on MRRSE typically come from national
statistics agencies, investment agencies, leading media houses,
trade unions, governments, and embassies.

10. Contact US:
Corporate Office
State Tower
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-730-0559
Email: sales@mrrse.com